日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies

NA-PHER2 试验中接受 HER2 靶向和内分泌治疗的 HER2+ER+ 乳腺癌的疗效和分子动力学决定因素

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-025-57293-9
Maurizio Callari, Matteo Dugo, Marco Barreca, Balázs Győrffy, Barbara Galbardi, Lucia Vigano, Alberta Locatelli, Chiara Dall'Ara, Marina Ferrarini, Giancarlo Bisagni, Marco Colleoni, Mauro Mansutti, Claudio Zamagni, Lucia Del Mastro, Stefania Zambelli, Antonio Frassoldati, Olivia Biasi, Lajos Puszta
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study

卡铂、依托泊苷、阿特珠单抗和贝伐珠单抗一线治疗广泛期小细胞肺癌患者：GOIRC-01-2019 CeLEBrATE 研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010694
Lamberti, Giuseppe; Rihawi, Karim; Mazzoni, Francesca; Riccardi, Ferdinando; Follador, Alessandro; Tiseo, Marcello; Frassoldati, Antonio; Colantonio, Ida; Bonetti, Andrea; Genova, Carlo; Giardina, Donatella; Bertolini, Federica; Cinieri, Saverio; Pasello, Giulia; Brighenti, Matteo; Andrini, Elisa; Tognetto, Michele; Boni, Luca; Ardizzoni, Andrea
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Intranasal Corticosteroids and Oral Montelukast for Paediatric Obstructive Sleep Apnoea: A Systematic Review

鼻内皮质类固醇和口服孟鲁司特治疗儿童阻塞性睡眠呼吸暂停：系统评价

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17050588
Zaffanello, Marco; Pietrobelli, Angelo; Nosetti, Luana; Antoniazzi, Franco; Frassoldati, Rossella; Piacentini, Giorgio
发表日期：2025
文献求助 收藏

Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer

早期HER2阳性乳腺癌的转移部位模式与内在亚型和HER2DX的关系

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djad179
Dieci, Maria Vittoria; Conte, PierFranco; Bisagni, Giancarlo; Bartolini, Stefania; Frassoldati, Antonio; Generali, Daniele; Piacentini, Federico; Griguolo, Gaia; Tagliafico, Enrico; Brasó Maristany, Fara; Chic, Nuria; Paré, Laia; Miglietta, Federica; Vicini, Roberto; D'Amico, Roberto; Balduzzi, Sara; Prat, Aleix; Guarneri, Valentina
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)

随机、开放标签、II期生物标志物研究，旨在探讨新辅助皮下注射曲妥珠单抗治疗局部晚期、炎症性或早期HER2阳性乳腺癌患者的免疫介导作用机制——Immun-HER试验（GOIRC-01-2016）

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007667
Pellegrino, Benedetta; Tommasi, Chiara; Serra, Olga; Gori, Stefania; Cretella, Elisabetta; Ambroggi, Massimo; Frassoldati, Antonio; Bisagni, Giancarlo; Casarini, Chiara; Bria, Emilio; Carbognin, Luisa; Fiorio, Elena; Mura, Antonella; Zamagni, Claudio; Gianni, Lorenzo; Zambelli, Alberto; Montemurro, Filippo; Tognetto, Michele; Todeschini, Renata; Missale, Gabriele; Campanini, Nicoletta; Silini, Enrico Maria; Maglietta, Giuseppe; Musolino, Antonino
肿瘤
炎症
HER2
肿瘤免疫
炎症/感染
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials

芳香化酶基因SNP预测早期乳腺癌患者的长期生存率和芳香化酶抑制剂毒性：GIM4和GIM5试验的生物标志物分析

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1568
Conte, Benedetta; Boni, Luca; Bisagni, Giancarlo; Durando, Antonio; Sanna, Giovanni; Gori, Stefania; Garrone, Ornella; Tamberi, Stefano; De Placido, Sabino; Schettini, Francesco; Pazzola, Antonio; Ponzone, Riccardo; Montemurro, Filippo; Lunardi, Gianluigi; Notaro, Rosario; De Angioletti, Maria; Turletti, Anna; Mansutti, Mauro; Puglisi, Fabio; Frassoldati, Antonio; Porpiglia, Mauro; Fabi, Alessandra; Generali, Daniele; Scognamiglio, Giovanni; Rossi, Maura; Brasó-Maristany, Fara; Prat, Aleix; Cardinali, Barbara; Piccioli, Patrizia; Serra, Martina; Lastraioli, Sonia; Bighin, Claudia; Poggio, Francesca; Lambertini, Matteo; Del Mastro, Lucia
肿瘤
毒理研究
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies

根据国际共识指南对晚期乳腺癌进行内分泌耐药/敏感性分类的预后和临床影响：来自 Mammella InterGruppo (MIG) 和 Gruppo Italiano Mammella (GIM) 研究的个体患者水平分析

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.101931
Lambertini, Matteo; Blondeaux, Eva; Bisagni, Giancarlo; Mura, Silvia; De Placido, Sabino; De Laurentiis, Michelino; Fabi, Alessandra; Rimanti, Anita; Michelotti, Andrea; Mansutti, Mauro; Russo, Antonio; Montemurro, Filippo; Frassoldati, Antonio; Durando, Antonio; Gori, Stefania; Turletti, Anna; Tamberi, Stefano; Urracci, Ylenia; Fregatti, Piero; Razeti, Maria Grazia; Caputo, Roberta; De Angelis, Carmine; Sanna, Valeria; Gasparini, Elisa; Agostinetto, Elisa; de Azambuja, Evandro; Poggio, Francesca; Boni, Luca; Del Mastro, Lucia
肿瘤
MIG
乳腺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial

辅助内分泌治疗类型与早期HR阳性/HER2阳性乳腺癌患者的无病生存期：来自III期随机ShortHER试验的分析

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-023-00509-2
Dieci, Maria Vittoria; Bisagni, Giancarlo; Bartolini, Stefania; Frassoldati, Antonio; Vicini, Roberto; Balduzzi, Sara; D'amico, Roberto; Conte, Pierfranco; Guarneri, Valentina
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial

作者更正：早期 HR 阳性/HER2 阳性乳腺癌患者的辅助内分泌治疗类型与无病生存期：来自 III 期随机 ShortHER 试验的分析

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-023-00532-3
Dieci, Maria Vittoria; Bisagni, Giancarlo; Bartolini, Stefania; Frassoldati, Antonio; Vicini, Roberto; Balduzzi, Sara; D'amico, Roberto; Conte, Pierfranco; Guarneri, Valentina
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?

免疫检查点抑制剂在“特殊”非小细胞肺癌人群中的应用：一种可行的方法？

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241612622
Bronte, Giuseppe; Cosi, Donato Michele; Magri, Chiara; Frassoldati, Antonio; Crinò, Lucio; Calabrò, Luana
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏